Monkeypox testing kit: India’s first kit by Mumbai-based Transasia Bio-Medicals
- Posted by pharmacyinfoline
- Posted in Disease
Monkeypox testing kit: India’s first kit by Mumbai-based Transasia Bio-Medicals
India has developed the first indigenously-developed RT- PCR kit for testing monkeypox disorder. Developed by TransasiaBio-Medicals, the kit was unveiled by Principal Scientific Adviser to the Centre Ajay Kumar Sood.
Founder- chairman of Transasia Suresh Vazirani said the kit would help in early discovery and better handling of the infection which the WHO declared a public health crisis of multinational concern.
Meanwhile, the Indian Council of Medical Research( ICMR) may conduct a serosurvey among connections of monkeypox cases to check for the presence of antibodies and find out how numerous of them were asymptomatic.
According to WHO, monkeypox is a viral zoonosis– a disease transmitted to humans from creatures– with symptoms analogous to smallpox although clinically less severe.
Monkeypox generally manifests itself with fever, rash, and blown lymph nodes and may lead to a range of medical complications. It’s generally a character-limited disease with symptoms lasting for two to four weeks.
The Guidelines on the administration of Monkeypox Disease’ issued by the Centre stated that mortal-to-mortal transmission occurs primarily through large respiratory driblets generally bearing stretched close contact.
It can also be transmitted through direct contact with body fluids or lesions, and circular contact with lesion material similar to contaminated apparel or linen of an infected person. creature-to-human transmission may occur by bite or scrape of infected creatures or through bushmeat medication.
The symptoms include lesions that generally begin within one to three days from the onset of fever, lasting for around two to four weeks, and are frequently described as painful until the recovery phase when they grow itchy. A notable partiality for palm and soles is characteristic of monkeypox, the guidelines stated.
The World Health Organisation has declared monkeypox a global public health breaking point of multinational concern.
About Transasia Bio-Medicals:
Transasia Bio-Medicals was founded in 1979 by Mr Suresh Vazirani who recognized the need for dedicated healthcare solutions for developing nations after witnessing the shortcomings of the healthcare systems in his home country India.
Transasia Bio-Medicals was founded in 1979 by Mr Suresh Vazirani who recognized the need for dedicated healthcare solutions for developing nations after witnessing the shortcomings of the healthcare systems in his home country India.
He quickly identified the need for quality, affordable diagnoses in low-income groups that could not afford expensive treatments for cure. In developing nations with exponentially growing populations and limited means to tackle challenges on multiple fronts, resources dedicated to preventing and hindering disease result in a greater impact rather than those focusing on the more costly, risky and lengthy treatments for cure.
After partnering with multiple diagnostics companies from around the world to service this need, he found that their products were unable to make a significant impact in these inadequately developed environments. Their products were not suited to a highly fragmented, price-sensitive market with poor infrastructure and expertise.
Committed to finding a solution, in 1995 he started Erba Mannheim, Germany with the vision to make world-class European technology accessible to emerging markets. He combined it with efficient, low-cost manufacturing and unparalleled market expertise to create the first fully integrated In-vitro Diagnostics company dedicated to fulfilling the needs of emerging market customers.
Contact Information:
8 Chandivali Studio Road, Andheri East, Powai, Mumbai, Maharashtra – 400072
Contact No: 1800 103 8226
email ID: transasia@transasia.co.in
Recommended readings:
Suggested readings:
